Thetetrasaccharide4,asubstructureofgangliosideGQ1bα,showsaremarkableaffinityforthemyelinassociatedglycoprotein(MAG)andwasthereforeselectedasstartingpointforaleadoptimizationprogram.Inour searchforstructurallysimplifiedandpharmacokineticallyimprovedmimicsof4,antagonistswithmodificationsof thecoredisaccharideGalb(1-3)GalNAc,aswellastheterminalα(2-3)-andtheinternalα(2-6)-linkedneuraminic acidweresynthesizedandtestedintarget-basedbindingassays.Comparedtothereferencetetrasaccharide4, themostpotentantagonist17exhibitsa360-foldimprovedaffinity.Furthermore,pharmacokineticparameters suchasstabilityinthecerebrospinalfluid,logDandpermeationthroughtheBBBindicatethedrug-likepropertiesofantagonist17.